Minoxidil
- Generic Name
- Minoxidil
- Brand Names
- Loniten, Minox, Regoxidine, Rogaine
- Drug Type
- Small Molecule
- Chemical Formula
- C9H15N5O
- CAS Number
- 38304-91-5
- Unique Ingredient Identifier
- 5965120SH1
- Background
A potent direct-acting peripheral vasodilator (vasodilator agents) that reduces peripheral resistance and produces a fall in blood pressure.
- Indication
For the treatment of severe hypertension and in the topical treatment (regrowth) of androgenic alopecia in males and females and stabilisation of hair loss in patients with androgenic alopecia.
- Associated Conditions
- Androgenetic Alopecia (AGA), Severe, symptomatic Hypertension
- Associated Therapies
- -
Efficacy and Safety Study to Compare Two Minoxidil Formulations on Women With Androgenetic Alopecia
- First Posted Date
- 2009-08-13
- Last Posted Date
- 2011-11-18
- Lead Sponsor
- Charite University, Berlin, Germany
- Target Recruit Count
- 113
- Registration Number
- NCT00958750
- Locations
- 🇩🇪
Charité-Universitaetsmedizin; Clinical Research Center for Hair and Skin Science, Berlin, Germany
Efficacy of Minoxidil in Children With Williams-Beuren Syndrome
- First Posted Date
- 2009-04-06
- Last Posted Date
- 2019-07-26
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 21
- Registration Number
- NCT00876200
- Locations
- 🇫🇷
Service de Cardiologie - Hôpital des Enfants, Toulouse, France
🇫🇷Service de Cardiologie Infantile, CHU Nancy, Nancy, France
🇫🇷Service de Cardiologie Pédiatrique, Hôpital Necker Enfants Malades, Paris, France
Pilot Study of the Treatment of Vascular Endothelial Growth Factor(VEGF)Signaling Pathway Inhibitor-Induced Hypertension
- Conditions
- Interventions
- First Posted Date
- 2008-02-05
- Last Posted Date
- 2014-06-10
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 2
- Registration Number
- NCT00607477
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
Efficacy of Therapy With the Spironolactone Pills Compared to Minoxidil Lotion in Female Pattern Hair Loss
- Conditions
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2017-03-03
- Lead Sponsor
- University of British Columbia
- Target Recruit Count
- 40
- Registration Number
- NCT00175617
- Locations
- 🇨🇦
UBC Division of Dermatology, Hair Research and Treatment Centre, Vancouver, British Columbia, Canada
A Study to Evaluate the Effectiveness and Safety of 5 Percent Minoxidil Foam in the Treatment of Male Pattern Hair Loss
- First Posted Date
- 2005-09-09
- Last Posted Date
- 2016-09-30
- Target Recruit Count
- 352
- Registration Number
- NCT00151515
- Locations
- 🇺🇸
Pfizer Investigational Site, Salt Lake City, Utah, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.